In the News

1861 News Items found
Fish, asparagus, and lemon on a plate
Q&A
Learn about the Mediterranean diet and how it could be beneficial for cancer survivors. Always check with your care team before making any changes to your diet.
Sheree Scarlett
Feature
Meet Sheree Scarlett, who helps to promote the wellness-related resources available to employees in her role in Employee Health and Wellness Services at MSK.
Learn about ashwagandha, an herb used for stress relief.
Learn about ashwagandha, an herb used for stress relief.
Cycle for Survival is a powerful fundraising phenomenon with the goal to beat rare cancers, raising nearly $300 million so far.
Cancer often leaves those it touches consumed with a feeling of hopelessness. But sometimes that feeling can motivate clinicians, patients, and supporters alike to turn soul-crushing moments into positive change.
Alexandra Joyner, Ming Li, and Kenneth Offit
Three faculty members from Memorial Sloan Kettering Cancer Center (MSK) and Sloan Kettering Institute (SKI) have been elected to the 2021 class of American Association for the Advancement of Science (AAAS) Fellows.
Craig B. Thompson
Craig B. Thompson, MD, President and CEO of Memorial Sloan Kettering Cancer Center (MSK), has been named to City & State’s 2022 Health Care Power 100 list.
Man and woman looking at camera and smiling.
A low-dose radiation approach could help more patients avoid side effects of treatment for head and neck cancer.
Lab worker dressed in “bunny suit” working with machine.
A new type of engineered immune cell could be a potent treatment for cancers that have escaped other immunotherapies.
Luis Parada in his lab
In the Lab
In a new study, MSK researchers looked at why glioblastoma brain tumors usually come back after treatment. Their findings suggest that a subset of cells — cancer stem cells — are able to evade current treatments because they are not actively dividing, and that these cells later form new tumors.
Memorial Sloan Kettering physician-scientist Michel Sadelain.
A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.